biospecimen_aliquot__bcr_aliquot_barcode	tcga-ar-a0u2-01a-11d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	f0194733-2347-43c4-a4a3-131642c27798
biospecimen_aliquot__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_aliquot__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016169
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	1.82
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.97
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ar-a0u2-01a-11d
biospecimen_analyte__bcr_analyte_uuid	f6e75cf8-3fde-42ae-af3a-73cc55f5d921
biospecimen_analyte__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_analyte__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_analyte__concentration	0.13
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ar-a0u2
biospecimen_diagnostic_slides__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	03e2add9-f20f-44da-93d1-d10bbd3844a5
biospecimen_normal_control__bcr_patient_barcode	tcga-ar-a0u2
biospecimen_normal_control__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_normal_control__ncedna_dna_conc	0.25
biospecimen_normal_control__ncedna_dna_qm	spec
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	80
biospecimen_portion__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_portion__bcr_portion_barcode	tcga-ar-a0u2-01a-11
biospecimen_portion__bcr_portion_uuid	56ac8269-59b7-4cd7-a0f2-b9cb2c49d208
biospecimen_portion__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_portion__date_of_creation	2010-09-10
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ar-a0u2-01a-11d
biospecimen_protocol__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_protocol__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_sample__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_sample__bcr_sample_uuid	7c8b0e74-bd47-4c5c-99de-8484eca2b1ad
biospecimen_sample__days_to_collection	2395
biospecimen_sample__initial_weight	150
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ar-a0u2.51f69645-9564-4257-a86e-3a574c27034f.pdf
biospecimen_sample__pathology_report_uuid	51f69645-9564-4257-a86e-3a574c27034f
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	bb541d0b-a4ba-482a-b4ff-427185e70239
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13d
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ar-a0u2-01a-21-a13d-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
biospecimen_slide__bcr_sample_barcode	tcga-ar-a0u2-01a
biospecimen_slide__bcr_slide_barcode	tcga-ar-a0u2-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	cb8df340-904c-4ff0-ac21-6f96d7c52d11
biospecimen_slide__image_file_name	tcga-ar-a0u2-01a-01-tsa.cb8df340-904c-4ff0-ac21-6f96d7c52d11.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	20
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	90
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ar-a0u2
biospecimen_tumor_sample__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_drug__bcr_drug_barcode	tcga-ar-a0u2-d19592
clinical_drug__bcr_drug_uuid	cb681be2-02b4-4823-bbe4-e34a66e10e57
clinical_drug__bcr_patient_barcode	tcga-ar-a0u2
clinical_drug__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_drug__form_completion_date	2011-12-15
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	doxorubicin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__regimen_number	1
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-ar-a0u2-f18483
clinical_follow_up__bcr_followup_uuid	c7f93bf3-479c-4ce3-ac96-debdbe56649c
clinical_follow_up__bcr_patient_barcode	tcga-ar-a0u2
clinical_follow_up__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_follow_up__death_days_to	2551
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-12-15
clinical_follow_up__new_tumor_event_dx_days_to	1609
clinical_follow_up__new_tumor_event_dx_indicator	yes
clinical_follow_up__new_tumor_event_site	bone
clinical_follow_up__new_tumor_event_site_other	liver
clinical_follow_up__new_tumor_event_type	distant metastasis
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__vital_status	dead
clinical_nte__bcr_patient_barcode	tcga-ar-a0u2
clinical_nte__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_nte__nte_cent_17_her2_ratio	2.47
clinical_nte__nte_er_status	positive
clinical_nte__nte_er_status_ihc__positive	70-79%
clinical_nte__nte_her2_fish_status	negative
clinical_nte__nte_her2_positivity_ihc_score	2+
clinical_nte__nte_her2_status	negative
clinical_nte__nte_pr_status_by_ihc	negative
clinical_patient__age_at_diagnosis	47
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n2
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left lower outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-ar-a0u2
clinical_patient__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_patient__birth_days_to	-17390
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__death_days_to	2551
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	10-19%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-2-24
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2004
clinical_patient__lymph_nodes_examined_count	16
clinical_patient__lymph_nodes_examined_he_count	4
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__margin_status_reexcision	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__metastasis_site	bone|liver
clinical_patient__method_initial_path_dx	incisional biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__nte_cent_17_her2_ratio	2.47
clinical_patient__nte_er_status	positive
clinical_patient__nte_er_status_ihc__positive	70-79%
clinical_patient__nte_her2_fish_status	negative
clinical_patient__nte_her2_positivity_ihc_score	2+
clinical_patient__nte_her2_status	negative
clinical_patient__nte_pr_status_by_ihc	negative
clinical_patient__patient_id	a0u2
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	ar
clinical_patient__tumor_status	with tumor
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	dead
clinical_radiation__bcr_patient_barcode	tcga-ar-a0u2
clinical_radiation__bcr_patient_uuid	9ad603dc-3fd0-44f5-ae4e-64eeb1ae8d6d
clinical_radiation__bcr_radiation_barcode	tcga-ar-a0u2-r19591
clinical_radiation__bcr_radiation_uuid	572ad134-752f-4fad-b70b-3fb15869115b
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2011-12-15
clinical_radiation__radiation_adjuvant_fractions_total	28
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A0U2-01A-11D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-AR-A0U2-01A-11D-A10G-09.bed.meta
manually_curated__id	tcga-ar-a0u2-01a-11d-a10g-09
manually_curated__md5sum	2fc738b4e41f4ba64c581c4a8826a5c4
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	f0194733-2347-43c4-a4a3-131642c27798
manually_curated__tumor_tag	brca
